These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12163084)

  • 21. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
    Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk Stratification for Cardiac Allograft Vasculopathy in Heart Transplant Recipients - Annual Intravascular Ultrasound Evaluation.
    Sato T; Seguchi O; Ishibashi-Ueda H; Yanase M; Okada N; Kuroda K; Hisamatsu E; Sunami H; Watanabe T; Nakajima S; Wada K; Hata H; Fujita T; Fukushima N; Kobayashi J; Nakatani T
    Circ J; 2016; 80(2):395-403. PubMed ID: 26701183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of plaque burden on compensatory enlargement of coronary arteries in cardiac allograft vasculopathy. Working Group on Cardiac Allograft Vasculopathy.
    Pethig K; Heublein B; Wahlers T
    Am J Cardiol; 1997 Jan; 79(1):89-92. PubMed ID: 9024747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of donor gender on allograft vasculopathy: evidence from intravascular ultrasound.
    Erinc K; Yamani MH; Starling RC; Young JB; Crowe T; Ratliff NB; Cook DJ; Hobbs R; Bott-Silverman C; Rincon G; Smedira N; Tuzcu EM
    Transplant Proc; 2004 Dec; 36(10):3129-31. PubMed ID: 15686711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death.
    Hollenberg SM; Klein LW; Parrillo JE; Scherer M; Burns D; Tamburro P; Oberoi M; Johnson MR; Costanzo MR
    Circulation; 2001 Dec; 104(25):3091-6. PubMed ID: 11748106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does acute rejection correlate with the development of transplant coronary artery disease? A multicenter study using intravascular ultrasound. Sandoz/CVIS Investigators.
    Kobashigawa JA; Miller L; Yeung A; Hauptman P; Ventura H; Wilensky R; Valantine H; Wiedermann J
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S221-6. PubMed ID: 8719490
    [No Abstract]   [Full Text] [Related]  

  • 27. Optical coherence tomography and intravascular ultrasound evaluation of cardiac allograft vasculopathy with and without intimal neovascularization.
    Ichibori Y; Ohtani T; Nakatani D; Tachibana K; Yamaguchi O; Toda K; Akasaka T; Fukushima N; Sawa Y; Komuro I; Kotani J; Sakata Y
    Eur Heart J Cardiovasc Imaging; 2016 Jan; 17(1):51-8. PubMed ID: 25976347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years.
    Kobashigawa JA; Tobis JM; Starling RC; Tuzcu EM; Smith AL; Valantine HA; Yeung AC; Mehra MR; Anzai H; Oeser BT; Abeywickrama KH; Murphy J; Cretin N
    J Am Coll Cardiol; 2005 May; 45(9):1532-7. PubMed ID: 15862430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in coronary endothelial function predict progression of allograft vasculopathy after heart transplantation.
    Hollenberg SM; Klein LW; Parrillo JE; Scherer M; Burns D; Tamburro P; Bromet D; Satran A; Costanzo MR
    J Heart Lung Transplant; 2004 Mar; 23(3):265-71. PubMed ID: 15019634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracoronary ultrasound assessment of morphological and functional abnormalities associated with cardiac allograft vasculopathy.
    Heroux AL; Silverman P; Costanzo MR; O'Sullivan EJ; Johnson MR; Liao Y; McKiernan TL; Balhan JE; Leya FS; Mullen GM
    Circulation; 1994 Jan; 89(1):272-7. PubMed ID: 8281657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac allograft vasculopathy: the central pathogenetic role of ischemia-induced endothelial cell injury.
    Day JD; Rayburn BK; Gaudin PB; Baldwin WM; Lowenstein CJ; Kasper EK; Baughman KL; Baumgartner WA; Hutchins GM; Hruban RH
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S142-9. PubMed ID: 8719476
    [No Abstract]   [Full Text] [Related]  

  • 32. Mild acute cellular rejection and development of cardiac allograft vasculopathy assessed by intravascular ultrasound and coronary angiography in heart transplant recipients-a SCHEDULE trial substudy.
    Nelson LM; Andreassen AK; Arora S; Andersson B; Gude E; Eiskjaer H; Rådegran G; Dellgren G; Gullestad L; Gustafsson F
    Transpl Int; 2020 May; 33(5):517-528. PubMed ID: 31958178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pathogenesis of cardiac allograft vasculopathy.
    Dong C; Redenbach D; Wood S; Battistini B; Wilson JE; McManus BM
    Curr Opin Cardiol; 1996 Mar; 11(2):183-90. PubMed ID: 8736690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiogenic shock and coronary endothelial dysfunction predict cardiac allograft vasculopathy after heart transplantation.
    Lopez-Fernandez S; Manito-Lorite N; Gómez-Hospital JA; Roca J; Fontanillas C; Melgares-Moreno R; Azpitarte-Almagro J; Cequier-Fillat A
    Clin Transplant; 2014 Dec; 28(12):1393-401. PubMed ID: 25284267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnosis of rejection after heart transplantation].
    Nunoda S
    Kyobu Geka; 2007 Jul; 60(8 Suppl):685-91. PubMed ID: 17763670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of lipid abnormalities in development and progression of transplant coronary disease: a serial intravascular ultrasound study.
    Kapadia SR; Nissen SE; Ziada KM; Rincon G; Crowe TD; Boparai N; Young JB; Tuzcu EM
    J Am Coll Cardiol; 2001 Jul; 38(1):206-13. PubMed ID: 11451276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation.
    Potena L; Masetti M; Sabatino M; Bacchi-Reggiani ML; Pece V; Prestinenzi P; Dall'Ara G; Taglieri N; Saia F; Fallani F; Magnani G; Rapezzi C; Grigioni F
    J Heart Lung Transplant; 2015 Sep; 34(9):1146-53. PubMed ID: 25843518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation.
    Tuzcu EM; Kapadia SR; Sachar R; Ziada KM; Crowe TD; Feng J; Magyar WA; Hobbs RE; Starling RC; Young JB; McCarthy P; Nissen SE
    J Am Coll Cardiol; 2005 May; 45(9):1538-42. PubMed ID: 15862431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
    Eisen HJ; Tuzcu EM; Dorent R; Kobashigawa J; Mancini D; Valantine-von Kaeppler HA; Starling RC; Sørensen K; Hummel M; Lind JM; Abeywickrama KH; Bernhardt P;
    N Engl J Med; 2003 Aug; 349(9):847-58. PubMed ID: 12944570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravascular ultrasound imaging after cardiac transplantation: advantage of multi-vessel imaging.
    Kapadia SR; Ziada KM; L'Allier PL; Crowe TD; Rincon G; Hobbs RE; Bott-Silverman C; Young JB; Nissen SE; Tuzcu EM
    J Heart Lung Transplant; 2000 Feb; 19(2):167-72. PubMed ID: 10703693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.